Related Experiment Video
Updated: May 11, 2026

Genome-wide Screen for miRNA Targets Using the MISSION Target ID Library
Published on: April 6, 2012
CpG island hypermethylation-associated silencing of microRNAs promotes human endometrial cancer
1Department of Obstetrics and Gynecology, Shanghai First People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, 650 New Songjiang Road, Shanghai 201620, China. xiaopingwan61@gmail.com.
Background:
Endometrial cancer (EC) is the most common gynecologic malignancy, but the molecular events involved in the development and progression of EC remain unclear. This study aimed to explore epigenetic modification of genes and miRNAs involved in EC development.
Methods:
Ishikawa and AN3CA cells were treated with 5'-Aza-2-deoxycytidine or histone deacetylase inhibitor. The expression of miRNAs and related genes were detected by PCR and Western blot. Promoter methylation was detected by bisulfite specific PCR sequencing. The proliferation, colony formation, cell cycle progression, migration and invasion of EC cells were evaluated by MTT, soft agar assay, flow cytometry, wound healing and invasion assay, respectively.
Results:
Aberrant expression of miRNAs including miR-200b, miR-130a/b, miR-625 and miR-222 was associated with tumorigenesis and metastasis in endometrial cancer. Silencing of miR-130b induced E-cadherin expression, while ectopic expression of miR-130b and knockdown of DICER1 increased the expression of Vimentin, zeb2, N-cadherin, Twist and Snail in EC cells. Furthermore, 5'-Aza-2-deoxycytidine and Histone deacetylase (HDAC) inhibitor inhibited the proliferation, colony formation, migration and invasion of EC cells, accompanied by reduced MMP secretion.
Conclusions:
Our study provides the first description of epigenetic modification of epithelial mesenchymal transition associated genes and miRNAs in EC cells, which are extensively involved in the regulation of gene expression and subsequent accumulation of malignant features of EC cells.
Insights
Epigenetic modifications in endometrial cancer (EC) influence gene expression and cell behavior. Targeting these epigenetic changes with drugs like 5'-Aza-2-deoxycytidine and HDAC inhibitors can suppress EC cell proliferation and metastasis.
Area of Science:
- Oncology
- Molecular Biology
- Epigenetics
Background:
- Endometrial cancer (EC) is a prevalent gynecologic malignancy with unclear molecular underpinnings.
- Understanding the epigenetic landscape of EC is crucial for developing targeted therapies.
Purpose of the Study:
- To investigate the role of epigenetic modifications in endometrial cancer development.
- To explore the impact of epigenetic alterations on genes and microRNAs (miRNAs) involved in EC progression.
Main Methods:
- Utilized Ishikawa and AN3CA endometrial cancer cell lines.
- Administered 5 ac{'-'}Aza-2-deoxycytidine and histone deacetylase (HDAC) inhibitors.
- Assessed miRNA and gene expression via PCR and Western blot; analyzed promoter methylation using bisulfite sequencing.
- Evaluated cellular proliferation, colony formation, cell cycle, migration, and invasion using standard assays.
Main Results:
- Identified aberrant expression of specific miRNAs (miR-200b, miR-130a/b, miR-625, miR-222) linked to EC tumorigenesis and metastasis.
- Demonstrated that miR-130b modulation affects epithelial-mesenchymal transition (EMT) markers like E-cadherin and Vimentin.
- Showed that epigenetic drugs (5 ac{'-'}Aza-2-deoxycytidine, HDAC inhibitor) significantly inhibited EC cell proliferation, colony formation, migration, and invasion, reducing matrix metalloproteinase (MMP) secretion.
Conclusions:
- This study elucidates the epigenetic regulation of EMT-associated genes and miRNAs in endometrial cancer.
- These epigenetic modifications are key regulators of gene expression, contributing to the malignant phenotype of EC cells.
- Findings highlight potential therapeutic strategies targeting epigenetic mechanisms in EC.
Related Concept Videos
MicroRNAs
MicroRNAs
Epigenetic Regulation
Epigenetic Regulation
X-chromosome...
Induced Pluripotent Stem Cells
Somatic cells are...
